Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

Revelation Biosciences (NASDAQ:REVB) will participate in the 38th Annual Roth Conference in Dana Point, CA, on March 23–24, 2026.

Rhea-AI Summary

Revelation Biosciences (NASDAQ:REVB) will participate in the 38th Annual Roth Conference in Dana Point, CA, on March 23–24, 2026. CEO James Rolke and CFO Chester S. Zygmont III will attend, and the company will hold a fireside chat on March 24, 2026 at 2:00 p.m. PT.

The fireside chat will be webcast live and later posted in the Investors section at www.RevBiosciences.com. Investors seeking meetings should contact their Roth representative.

Argus Mar 19 session

-1.64% close to close Open Argus

Details

News Market Reaction – REVB

In the Mar 19 session, REVB declined 1.64%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement centers on REVB’s participation in a fireside chat at the 38th Annual Roth Confere...

Analysis

This announcement centers on REVB’s participation in a fireside chat at the 38th Annual Roth Conference, providing another forum to discuss its Gemini program and recent financings. Historically, key milestones such as the FDA’s Phase 2/3 pathway agreement and warrant inducement deals have been followed by mixed share reactions. Investors may watch how management frames clinical timelines, capital needs, and the existing S-3/A warrant shelf when evaluating future developments.

Key Figures

Conference edition: 38th Annual Roth Conference Conference dates: March 23–24 Fireside chat date: March 24, 2026 +1 more

Conference edition

38th Annual Roth Conference

Investor conference attendance

Conference dates

March 23–24

REVB attendance at Roth Conference

Fireside chat date

March 24, 2026

Scheduled company fireside chat

Fireside chat time

2:00 p.m. PT

Timing of Roth Conference fireside chat

Historical Context

5 past events · Latest: Feb 26

5 events

1. Feb 26

   Earnings and update

   24h Move

   -0.8%

   Year-end 2025 results, cash runway into Q1 2027, Gemini clinical progress.

2. Jan 26

   Reverse stock split

   24h Move

   -14.8%

   1-for-4 reverse split to address Nasdaq minimum bid listing requirement.

3. Jan 23

   Warrant inducement deal

   24h Move

   -24.4%

   Immediate exercise of warrants for ~$11M gross proceeds and new Class J warrants.

4. Jan 21

   FDA pathway agreement

   24h Move

   -10.1%

   FDA agreement on single adaptive Phase 2/3 Gemini study in AKI (~300 patients).

5. Jan 14

   Conference data presentation

   24h Move

   -0.6%

   PRIME study data on Gemini at critical care nephrology conference in San Diego.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, CA / ACCESS Newswire / March 19, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, announced today that James Rolke, Revelation's Chief Executive Officer, and Chester S. Zygmont, III, Revelation's Chief Financial Officer, will be attending the 38^th Annual Roth Conference, in Dana Point, CA, on Monday and Tuesday March 23^rd and 24^th. On Tuesday, March 24, 2026, at 2:00 p.m. PT, the Company will participate in a fireside chat.

The fireside chat will be webcast live here and available on our Investors section of the Revelation Biosciences website, www.RevBiosciences.com, after the meeting.

Investors who wish to schedule a meeting with Revelation's management during the conference should contact their Roth representative.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on rebalancing inflammation using its proprietary formulation, Gemini. Revelation has multiple ongoing programs to evaluate Gemini as a treatment for acute kidney injury, a treatment of chronic kidney disease, prevention of post-surgical infection, and a treatment to reduce hyperinflammation and infection associated with severe burn.

For more information, please visit www.RevBiosciences.com.

Company Contacts

Mike Porter
Investor Relations
Porter LeVay & Rose Inc.
Email: mike@plrinvest.com

Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: czygmont@revbiosciences.com

SOURCE: Revelation Biosciences, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Revelation Biosciences (REVB) present at the 38th Annual Roth Conference?

Revelation will participate on March 23–24, 2026 with a fireside chat on March 24 at 2:00 p.m. PT. According to Revelation, CEO James Rolke and CFO Chester S. Zygmont III will attend and represent the company at the conference.

How can investors watch the Revelation Biosciences (REVB) fireside chat on March 24, 2026?

The fireside chat will be webcast live and then archived on the company's investor site. According to Revelation, the webcast will be available live and later in the Investors section at www.RevBiosciences.com after the meeting.

Who from Revelation Biosciences (REVB) will attend the Roth Conference in March 2026?

CEO James Rolke and CFO Chester S. Zygmont III will attend the Roth Conference on March 23–24, 2026. According to Revelation, both executives will participate in meetings and the company’s March 24 fireside chat.

Can investors schedule one-on-one meetings with Revelation Biosciences (REVB) at the Roth Conference?

Yes. Investors should arrange meetings through their Roth representative to meet Revelation management during the conference. According to Revelation, interested investors must contact their Roth representative to schedule meetings with company executives.

Where will the recording of Revelation Biosciences (REVB) fireside chat be available after the Roth Conference?

The recording will be posted in the Investors section of Revelation's website after the event. According to Revelation, the webcast will remain available on www.RevBiosciences.com following the March 24, 2026 fireside chat.

What time is the Revelation Biosciences (REVB) fireside chat at the 38th Annual Roth Conference on March 24, 2026?

The fireside chat is scheduled for 2:00 p.m. PT on Tuesday, March 24, 2026. According to Revelation, the session will be webcast live and accessible to investors via the company’s investor web pages.